Dr Donna Billingsley Ph D, PHD | |
Druid Chase 2801 Buford Hwy, N. E., Suite 540, Atlanta, GA 30329 | |
(404) 294-8688 | |
Not Available |
Full Name | Dr Donna Billingsley Ph D |
---|---|
Gender | Female |
Speciality | Psychologist |
Location | Druid Chase 2801 Buford Hwy, N. E., Atlanta, Georgia |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1851510515 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Dr Donna Billingsley Ph D, PHD Druid Chase 2801 Buford Hwy, N. E., Suite 540, Atlanta, GA 30329 Ph: (404) 294-8688 | Dr Donna Billingsley Ph D, PHD Druid Chase 2801 Buford Hwy, N. E., Suite 540, Atlanta, GA 30329 Ph: (404) 294-8688 |
News Archive
Some 20 percent of breast cancer survivors will suffer from lymphedema, a potentially severe side effect of treatment that makes arms swell with lymph. The disease is often overlooked, but commercially available app-based technology now makes early detection easier, allowing for proactive treatment.
Sorrento Therapeutics, Inc. and NantBioScience, Inc., a majority owned subsidiary of NantWorks, LLC, announced today that they have established a joint venture to focus on the development of 'first-in-class' small molecules against targets that have eluded the pharmaceutical industry to date and which may address important drivers of cancer growth including cancer stem cells.
A report, released Tuesday, from Oxfam International and Health Action International says the EU is putting big drug companies' interests ahead of "millions of people" in developing countries who do not have access to essential medicines, Agence France-Presse reports (10/20).
The move comes even as a report points at $6.7 billion in overspending in Medicare. The HHS inspector general also says that the program paid $457 million in 2012 to detect drugs after a sharp increase in prescription drug abuse.
Melanoma, the most serious form of skin cancer varies in size, shape and severity, and although pathologists and researchers often intuitively differentiate between types of melanomas, the variations have never been formally quantified and documented. A project involving RENCI and researchers in the University of North Carolina School of Medicine and the departments of computer science and statistics and operations research aims to change that by using image analysis techniques to improve melanoma classification.
› Verified 8 days ago